Enterprise Solutions Webinars

  1. Expand Your Capabilities And Shorten Your Time-To-Clinic 8/7/2025

    Gain expert insights into cell line development for biologics commercialization. and learn how CLD services—from DNA to GMP Master Cell Bank—can accelerate your path to clinical success.

  2. Streamline Production With A Final Filling Single-Use Set 8/7/2025

    Streamline your production with a Final Filling Single-Use Set that installs in under 10 minutes to eliminate cleaning and sterilization while ensuring Annex 1 compliance and full customization.

  3. Leverage Process Analytical Technology For Developing Novel Conjugates 7/29/2025

    Explore how Process Analytical Technology accelerates novel conjugate development and how PAT is integrated with an ADC platform to enhance efficiency, data quality, and product consistency.

  4. Resilience Capacity Update July 2025: Large Molecule Drug Substance 7/28/2025

    Hear from Evan Pasenello, Head of Commercial Services, about how Resilience can support large molecule programs from early phase through clinical and commercial manufacturing.

  5. Providing Development And Supply Of Life-Changing Medicines 7/28/2025

    Review the strategic application of extensive expertise in microbial systems to meet the increasing demand for novel biologics. Cutting-edge capabilities ensure streamlined development and manufacturing processes.

  6. Cytovance Biologics Capacity Update July 2025: Large Molecule Drug Substance 7/28/2025

    Thomas Kohl, Director of Business Development, shares the company’s microbial and mammalian capabilities and their available capacity. Cytovance delivers ingenuity end-to-end to both large pharma and biotech clients alike.

  7. Aragen Capacity Update July 2025: Large Molecule Drug Substance 7/28/2025

    Aragen’s newly built cutting-edge biologics manufacturing facility launches with GMP capabilities from 50L to 2000L—scaling to 5000L soon—with a DP filling line and ADC conjugation suite set to redefine bioproduction in India.

  8. PCI Pharma Services Capacity Update July 2025: Fill/Finish 7/28/2025

    PCI is positioned to meet the future of sterile pharmaceutical development and manufacturing with cutting-edge technology, and innovative solutions for high-value biologics, complex formulations, and lyophilized drug products.

  9. Novartis Contract Manufacturing Capacity Update July 2025: Fill/Finish 7/28/2025

    Novartis Contract Manufacturing introduces their fill and finish solutions and capacity. Explore an overview of the aseptic network of Novartis and the capabilities of each site.

  10. INCOG BioPharma Services Capacity Update July 2025: Fill/Finish 7/28/2025

    Our balanced framework addresses the unique challenges of sterile manufacturing by integrating risk-based decision making with systematic capacity planning.